Package 72205-406-02

{"route": ["ORAL"], "spl_id": "fb424a50-a319-4227-851f-2f59d236adf2", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "upc": ["0372205368187", "0372205368910", "0372205368996", "0372205406018", "0372205368606", "0372205368064", "0372205406025"], "unii": ["GLH0314RVC"], "rxcui": ["1116635", "1666332"], "spl_set_id": ["b1c29d47-960f-4fc4-b6ff-399e2c6eec4c"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (72205-406-01)", "package_ndc": "72205-406-01", "marketing_start_date": "20250719"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (72205-406-02)", "package_ndc": "72205-406-02", "marketing_start_date": "20250719"}, {"sample": false, "description": "1 BLISTER PACK in 1 CARTON (72205-406-04)  / 14 TABLET in 1 BLISTER PACK", "package_ndc": "72205-406-04", "marketing_start_date": "20250719"}], "brand_name": "TICAGRELOR", "product_id": "72205-406_fb424a50-a319-4227-851f-2f59d236adf2", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "72205-406", "generic_name": "TICAGRELOR", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TICAGRELOR", "active_ingredients": [{"name": "TICAGRELOR", "strength": "60 mg/1"}], "application_number": "ANDA208596", "marketing_category": "ANDA", "marketing_start_date": "20250719", "listing_expiration_date": "20271231"}